J Łopatyński

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

Björn Fagerberg, S. Edwards, T Halmos et al. · Diabetologia · 2005 · 114 citations · Full text

Insulin Resistance, Metabolic Syndrome, Diabetes Management +13

A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus.

J Łopatyński, G Mardarowicz, Grzegorz Szczęśniak · PubMed · 2003 · 60 citations

[The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (Eastern Poland)].

J Łopatyński, G Mardarowicz, Teresa Nicer et al. · PubMed · 2001 · 22 citations

Hypertension, Rural Areas, Type Ii +18

Pulmonary function between 40 and 80 years of age.

Stanisław Ostrowski, Anna Grzywa-Celińska, Jolanta Mieczkowska et al. · PubMed · 2005 · 22 citations

Spirometry Results, Reference Formulas, Advanced Lung Disease +12

[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].

Monika Buraczyńska, Piotr Książek, J Łopatyński et al. · PubMed · 2002 · 16 citations

Hypertension, Genetics, Renal Pathology +19